Tevra said it was competing with Bayer's Advantage and Advantix topical flea and tick treatments, and lost millions of dollars in revenue from its inability to more widely distribute its generic topical imidacloprid, the active ingredient in tick and flea treatment for cats and dogs.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/bBerJRD
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment